Joseph Kiani - Masimo Chairman of the Board, CEO
| MASI Stock | USD 137.00 0.75 0.55% |
Chairman
Mr. Joseph E. Kiani is the Chairman of the Board, Chief Executive Officer of Masimo Corporationration Mr. Kiani is an inventor on more than 100 patents related to signal processing, sensors and patient monitoring, including patents for the invention of Measurethrough motion and lowperfusion pulse oximetry. Since September 2016, Mr. Kiani has served on the Board of Directors of Stereotaxis, Inc., a manufacturer of robotic cardiology instrument navigation systems. From 1998 to March 2013, Mr. Kiani served on the Board of Directors of Saba Software, Inc., a publiclytraded software company focused on human capital development and management solutions since 1989.
| Age | 59 |
| Tenure | 35 years |
| Address | 52 Discovery, Irvine, CA, United States, 92618 |
| Phone | 949 297 7000 |
| Web | https://www.masimo.com |
Masimo Management Efficiency
The company has return on total asset (ROA) of 0.0293 % which means that it generated a profit of $0.0293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0603 %, meaning that it created $0.0603 on every $100 dollars invested by stockholders. Masimo's management efficiency ratios could be used to measure how well Masimo manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Masimo's Return On Tangible Assets are decreasing as compared to previous years. The Masimo's current Return On Capital Employed is estimated to increase to 0.14, while Return On Assets are projected to decrease to 0.04. As of now, Masimo's Total Current Assets are increasing as compared to previous years. The Masimo's current Intangible Assets is estimated to increase to about 1.3 B, while Non Currrent Assets Other are forecasted to increase to (481.5 M).Similar Executives
| Found 12 records | CHAIRMAN Age | ||
| Dick Allen | Tandem Diabetes Care | 73 | |
| Adam Elsesser | Penumbra | 62 | |
| Marilyn Nelson | Inspire Medical Systems | 81 | |
| Curt Hartman | CONMED | 60 | |
| Thomas Burns | Glaukos Corp | 63 | |
| Mark Tryniski | CONMED | 60 | |
| Terrance Gregg | DexCom Inc | 68 | |
| Daniel Moore | LivaNova PLC | 57 | |
| Lonnie Smith | Tandem Diabetes Care | 69 | |
| William Kozy | LivaNova PLC | 72 | |
| Jonathan Lord | DexCom Inc | 60 | |
| William Link | Glaukos Corp | 74 | |
Management Performance
| Return On Equity | 0.0603 | ||||
| Return On Asset | 0.0293 |
Masimo Leadership Team
Elected by the shareholders, the Masimo's board of directors comprises two types of representatives: Masimo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Masimo. The board's role is to monitor Masimo's management team and ensure that shareholders' interests are well served. Masimo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Masimo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yongsam Lee, CIO and Executive VP | ||
| Micah Young, CFO, Executive Vice President | ||
| Tao Levy, Executive Vice President - Business Development | ||
| David Ramshorst, Chief Accounting Officer | ||
| Rick Fishel, President of Worldwide OEM Bus. and Blood Management | ||
| Julie Shimer, Director | ||
| H Cohen, Director | ||
| Joseph Kiani, Chairman of the Board, CEO | ||
| Paul Jansen, Executive Vice President - Marketing and Clinical Development | ||
| Bilal Muhsin, Executive Vice President Engineering, Marketing & Regulatory Affairs | ||
| Adam Mikkelson, Director | ||
| Tom McClenahan, Executive Vice President General Counsel | ||
| Steven Barker, Chairman Officer | ||
| Craig Reynolds, Independent Director | ||
| Mark Raad, CFO and Executive VP of Fin. | ||
| Sanford Fitch, Independent Director | ||
| Thomas Harkin, Director | ||
| Eli Kammerman, Investor Relations Officer | ||
| Jack Lasersohn, Independent Director | ||
| Jon Coleman, President - Worldwide Sales, Professional Services and Medical Affairs | ||
| Joe Kiani, Founder, Chairman and CEO | ||
| John Coleman, President - Worldwide Sales, Professional Services and Medical Affairs | ||
| Thomas McClenahan, General VP | ||
| Paul Hataishi, Senior Officer | ||
| Anand Sampath, Ex Research |
Masimo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Masimo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0603 | ||||
| Return On Asset | 0.0293 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 8.02 B | ||||
| Shares Outstanding | 52.78 M | ||||
| Shares Owned By Insiders | 7.64 % | ||||
| Shares Owned By Institutions | 96.01 % | ||||
| Number Of Shares Shorted | 4.04 M | ||||
| Price To Earning | 35.69 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Masimo. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Masimo Stock please use our How to Invest in Masimo guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Masimo Stock analysis
When running Masimo's price analysis, check to measure Masimo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Masimo is operating at the current time. Most of Masimo's value examination focuses on studying past and present price action to predict the probability of Masimo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Masimo's price. Additionally, you may evaluate how the addition of Masimo to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Masimo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Masimo. If investors know Masimo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Masimo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Earnings Share 1.51 | Revenue Per Share 38.79 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0293 |
The market value of Masimo is measured differently than its book value, which is the value of Masimo that is recorded on the company's balance sheet. Investors also form their own opinion of Masimo's value that differs from its market value or its book value, called intrinsic value, which is Masimo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Masimo's market value can be influenced by many factors that don't directly affect Masimo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Masimo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Masimo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Masimo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.